Screening for Lynch Syndrome by Immunohistochemistry BRAF Mutations Analysis and MLH1 Promoter Methylation Analysis for Patients in Ontario with Colorectal or Endometrial Cancers. This evidence concerns the gene MLH1 and Lynch syndrome.